Insider Trading & SAST disclosures for Ajanta Pharma Ltd.

The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by VANDANA SHAILESH SINGH in Ajanta Pharma Ltd. where Disposal of 548 Equity Shares done at an average price of Rs. 2722.5 was reported to the exchange on Feb. 28, 2025.

The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by Aayush Agrawal, trustee Aayush Agrawal Trust in Ajanta Pharma Ltd. where Pledge of 70,000 shares done was reported to the exchange on March 7, 2025.

Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.